SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-009054
Filing Date
2020-01-16
Accepted
2020-01-16 16:56:09
Documents
13
Period of Report
2020-01-15
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d866228d8k.htm   iXBRL 8-K 28160
2 EX-3.1 d866228dex31.htm EX-3.1 108107
  Complete submission text file 0001193125-20-009054.txt   284314

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sgen-20200115.xsd EX-101.SCH 3091
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgen-20200115_lab.xml EX-101.LAB 18125
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgen-20200115_pre.xml EX-101.PRE 11419
12 EXTRACTED XBRL INSTANCE DOCUMENT d866228d8k_htm.xml XML 3478
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32405 | Film No.: 20531575
SIC: 2836 Biological Products, (No Diagnostic Substances)